-
Survivor Profile
Going Full BoreSusan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
-
Get Involved
Diversifying DonorsA diverse donor pool benefits patients in need of bone marrow transplants.
by Lindsey Konkel
-
Survivor Profile
Reasons to DreamDespite a metastatic lung cancer diagnosis, Emily Bennett Taylor was able to look beyond the illness in 2012 to her dream of raising a family. Today, with no evidence of disease, she is the mother of two baby girls.
by Marci A. Landsmann
-
Q&A
A Rare DriveChordoma survivor Josh Sommer brings together researchers and patients to develop better treatments for an uncommon cancer.
by Kate Yandell
-
From the Editor-in-Chief
Can Big Data Launch Cancer Research?Analysis of big data in cancer medicine will be key to delivering on the cancer moonshot.
by William G. Nelson, MD, PhD
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Forward Look
Vice President Joe Biden Brings “Moonshot” to AACR Annual MeetingVice President Joe Biden is leading a new, national $1 billion Moonshot initiative to propel cancer research. Speaking in April at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans, Biden emphasized the need for scientists to collaborate to move cancer research forward. “There is more brainpower in this room than exists […]
by Sue Rochman
-
Survivor Profile
In Support and ServiceRetired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
-
Biden Calls for Collaboration
Vice president cites immunotherapy, big data and team science as innovative ways to speed progress against cancer.
by Kevin McLaughlin
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles